Prevalence of metabolic syndrome and its relationship with cardiovascular disease among hypertensive patients 55-80 years of age

Acta Cardiologica Sinica

Volumn 27, Issue 4, 2011, Pages 229-237

  Su, Chun Hung ^a,b   Fang, Chih Yuan ^c   Chen, Jung Sheng ^d   Po, Helen L ^e   Chou, Li Ping ^f   Chiang, Chih Yeng ^g   Ueng, Kwo Chang ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d Chu Shang Show Chwan Hosptial ^*  (Taiwan)

^e MACKAY MEMORIAL HOSPITAL   (Taiwan)

^f Sin Lau Hospital   (Taiwan)

^g Cardinal Tien Hospital Yung Ho Branch   (Taiwan)

Author keywords

Cardiovascular disease; Hypertension; Metabolic syndrome; Prevalence

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PATIENT IDENTIFICATION; PREVALENCE; STROKE; TAIWAN;

EID: 84863014297     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16. (Pubitemid 35403784)
2. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245-50. (Pubitemid 39202340)
3. Lin YC, Hsu LA, Ko YS, et al. Impact of conventional cardiovascular risk factors on acute myocardial infarction in young adult Taiwanese. Acta Cardiol Sin 2010;26:228-34.
4. Cuspidi C, Meani S, Fusi V, et al. Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens 2004;22:1991-8. (Pubitemid 39336683)
5. Schillaci G, Pirro M, Vaudo G, et al. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 2004;19:1817-22. (Pubitemid 38622521)
6. World Health Organization. World Health Organization Consultation Report. Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva: WHO, 1999.
7. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
8. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Available at: http://www.idf.org/webdata/docs/IDF- Meta-def-final.pdf (accessed Dec 27, 2009).
9. World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment. Geneva: WHO, 2000.
10. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an american heart association/national heart, lung, and blood Institute scientific statement. Circulation 2005;112:2735-52. (Pubitemid 41532612)
11. Orchard TJ, Temprosa M, Goldberg R, et al. Diabetes prevention program research group. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the diabetes prevention program randomized trial. Ann Intern Med 2005;142:611-9. (Pubitemid 40529957)
12. WHO/MONICA-Project. Multinational Monitoring of Trends and Determinants in Cardiovascular Diseases (MONICAProject) and Manual of Operation. Geneva, Switzerland: World Health Organization, Cardiovascular Disease Unit, 1983.
13. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9. (Pubitemid 34251969)
14. Jia WP, Xiang KS, Chen L, et al. Acomparison of the application of two working definitions of metabolic syndrome in Chinese population. Zhonghua Yi Xue Za Zhi 2004;84:534-8. [Article in Chinese]
15. Jia WP, Xiang KS, Chen L, et al. Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China. Obes Rev 2002;3:157-65. (Pubitemid 34815234)
16. Dou XF, Zhang HY, Sun K, et al. Metabolic syndrome strongly linked to stroke in Chinese. Zhonghua Yi Xue Za Zhi 2004;84:539-42. [Article in Chinese]
17. Nestel P, Lyu R, Low LP, et al. Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Asia Pac J Clin Nutr 2007;16:362-7. (Pubitemid 46750768)
18. Nakanishi N, Takatorige T, Fukuda H, et al. Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men. Diabetes Res Clin Pract 2004;64:59-70. (Pubitemid 38249458)
19. Lin CC, Liu CS, Lai MM, et al. Metabolic syndrome in a Taiwanese metropolitan adult population. BMC Public Health 2007;7:239.
20. Meigs JB, D'Agostino RB Sr, Wilson PW, et al. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 1997;46:1594-600. (Pubitemid 27411235)
21. Wildman RP, Gu D, Reynolds K, et al. Are waist circumference and body mass index independently associated with cardiovascular disease risk in Chinese adults? Am J Clin Nutr 2005;82:1195-202. (Pubitemid 43779717)
22. Chobanian AV, Bakris GL, Black HR, et al. National heart, lung, and blood institute joint national committee on prevention, detection, evaluation, and treatment of high blood Pressure, national high blood pressure education program coordinating committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560-72.
23. European society of hypertension - European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53.
24. He Y, Jiang B, Wang J, et al. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol 2006;47:1588-94.
25. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. Third National Health and Nutrition Examination Survey (NHANES III), National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003;52:1210-4. (Pubitemid 36523358)
26. Rantala AO, Kauma H, Lilja M, et al. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med 1999;245:163-74. (Pubitemid 29089113)
27. Hsu CN, Chen YC, Wang TD. Prevalence and characteristics of the metabolic syndrome in Chinese hypertensive patients: a hospital-based observation. Acta Cardiol Sin 2005;21:89-97.